The negative regulation of phosphoinositide 3-kinase signaling by p85 and it's implication in cancer - PubMed (original) (raw)

. 2005 Oct;4(10):1309-12.

doi: 10.4161/cc.4.10.2062. Epub 2005 Oct 28.

Affiliations

• PMID: 16131837
• DOI: 10.4161/cc.4.10.2062

The negative regulation of phosphoinositide 3-kinase signaling by p85 and it's implication in cancer

Ji Luo et al. Cell Cycle. 2005 Oct.

Abstract

The phosphoinositide 3-kinase (PI3K) signaling pathway critically regulates cell growth and cell survival. Mutations that lead to aberrant activation of this pathway are frequent events in human cancers. Here we discuss some recent studies identifying the mechanisms by which p85, the regulatory subunit of PI3K, negatively regulates PI3K signaling. While necessary for the stability and membrane recruitment of the p110 catalytic subunit of PI3K. p85 represses the basal activity of p110 in the absence of growth factor stimulation. In its unbound, free form, p85 sequesters the adaptor protein IRS-1 and therefore limits the extent of PI3K signaling downstream of the insulin and IGF-1 receptors. These findings lend new insight to how changes in p85 gene dosage or mutations in p85 could lead to the hyper-activation of PI3K and thus contribute towards tumorigenesis.

PubMed Disclaimer

Similar articles

• Class IA PI3K regulatory subunits: p110-independent roles and structures.
  Fox M, Mott HR, Owen D. Fox M, et al. Biochem Soc Trans. 2020 Aug 28;48(4):1397-1417. doi: 10.1042/BST20190845. Biochem Soc Trans. 2020. PMID: 32677674 Free PMC article. Review.
• Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase.
  Chagpar RB, Links PH, Pastor MC, Furber LA, Hawrysh AD, Chamberlain MD, Anderson DH. Chagpar RB, et al. Proc Natl Acad Sci U S A. 2010 Mar 23;107(12):5471-6. doi: 10.1073/pnas.0908899107. Epub 2010 Mar 8. Proc Natl Acad Sci U S A. 2010. PMID: 20212113 Free PMC article.
• The p85 regulatory subunit of phosphoinositide 3-kinase down-regulates IRS-1 signaling via the formation of a sequestration complex.
  Luo J, Field SJ, Lee JY, Engelman JA, Cantley LC. Luo J, et al. J Cell Biol. 2005 Aug 1;170(3):455-64. doi: 10.1083/jcb.200503088. Epub 2005 Jul 25. J Cell Biol. 2005. PMID: 16043515 Free PMC article.
• Interaction of the retinal insulin receptor beta-subunit with the p85 subunit of phosphoinositide 3-kinase.
  Rajala RV, McClellan ME, Chan MD, Tsiokas L, Anderson RE. Rajala RV, et al. Biochemistry. 2004 May 18;43(19):5637-50. doi: 10.1021/bi035913v. Biochemistry. 2004. PMID: 15134438
• Molecular Mechanisms of Human Disease Mediated by Oncogenic and Primary Immunodeficiency Mutations in Class IA Phosphoinositide 3-Kinases.
  Dornan GL, Burke JE. Dornan GL, et al. Front Immunol. 2018 Mar 19;9:575. doi: 10.3389/fimmu.2018.00575. eCollection 2018. Front Immunol. 2018. PMID: 29616047 Free PMC article. Review.

Cited by

• The Small GTPase ARF6 Activates PI3K in Melanoma to Induce a Prometastatic State.
  Yoo JH, Brady SW, Acosta-Alvarez L, Rogers A, Peng J, Sorensen LK, Wolff RK, Mleynek T, Shin D, Rich CP, Kircher DA, Bild A, Odelberg SJ, Li DY, Holmen SL, Grossmann AH. Yoo JH, et al. Cancer Res. 2019 Jun 1;79(11):2892-2908. doi: 10.1158/0008-5472.CAN-18-3026. Epub 2019 May 2. Cancer Res. 2019. PMID: 31048499 Free PMC article.
• Embryonic vitamin D deficiency programs hematopoietic stem cells to induce type 2 diabetes.
  Oh J, Riek AE, Bauerle KT, Dusso A, McNerney KP, Barve RA, Darwech I, Sprague JE, Moynihan C, Zhang RM, Kutz G, Wang T, Xing X, Li D, Mrad M, Wigge NM, Castelblanco E, Collin A, Bambouskova M, Head RD, Sands MS, Bernal-Mizrachi C. Oh J, et al. Nat Commun. 2023 Jun 13;14(1):3278. doi: 10.1038/s41467-023-38849-z. Nat Commun. 2023. PMID: 37311757 Free PMC article.
• p85α is a microRNA target and affects chemosensitivity in pancreatic cancer.
  Toste PA, Li L, Kadera BE, Nguyen AH, Tran LM, Wu N, Madnick DL, Patel SG, Dawson DW, Donahue TR. Toste PA, et al. J Surg Res. 2015 Jun 15;196(2):285-293. doi: 10.1016/j.jss.2015.02.071. Epub 2015 Mar 6. J Surg Res. 2015. PMID: 25846727 Free PMC article.
• Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers.
  Geering B, Cutillas PR, Nock G, Gharbi SI, Vanhaesebroeck B. Geering B, et al. Proc Natl Acad Sci U S A. 2007 May 8;104(19):7809-14. doi: 10.1073/pnas.0700373104. Epub 2007 Apr 30. Proc Natl Acad Sci U S A. 2007. PMID: 17470792 Free PMC article.
• RNF43 G659fs is an oncogenic colorectal cancer mutation and sensitizes tumor cells to PI3K/mTOR inhibition.
  Fang L, Ford-Roshon D, Russo M, O'Brien C, Xiong X, Gurjao C, Grandclaudon M, Raghavan S, Corsello SM, Carr SA, Udeshi ND, Berstler J, Sicinska E, Ng K, Giannakis M. Fang L, et al. Nat Commun. 2022 Jun 8;13(1):3181. doi: 10.1038/s41467-022-30794-7. Nat Commun. 2022. PMID: 35676246 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon

• Miscellaneous

  • NCI CPTAC Assay Portal